<SEC-DOCUMENT>0001708599-25-000038-index.html : 20250410
<SEC-HEADER>0001708599-25-000038.hdr.sgml : 20250410
<ACCEPTANCE-DATETIME>20250410160312
ACCESSION NUMBER:		0001708599-25-000038
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250408
FILED AS OF DATE:		20250410
DATE AS OF CHANGE:		20250410

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Venkatesan Jay
		CENTRAL INDEX KEY:			0001413350
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38519
		FILM NUMBER:		25828317

	MAIL ADDRESS:	
		STREET 1:		C/O AYER CAPITAL MANAGEMENT, LP
		STREET 2:		230 CALIFORNIA ST, SUITE 600
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94111

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Serina Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001708599
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				821436829
		STATE OF INCORPORATION:			AL
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		601 GENOME WAY
		STREET 2:		SUITE 2001
		CITY:			HUNTSVILLE
		STATE:			AL
		ZIP:			35806
		BUSINESS PHONE:		(256) 327-9630

	MAIL ADDRESS:	
		STREET 1:		601 GENOME WAY
		STREET 2:		SUITE 2001
		CITY:			HUNTSVILLE
		STATE:			AL
		ZIP:			35806

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AgeX Therapeutics, Inc.
		DATE OF NAME CHANGE:	20170606
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>wk-form4_1744315385.xml
<DESCRIPTION>FORM 4
<TEXT>
Document 1 - file: wk-form4_1744315385.html

Document 1 - RAW XML: wk-form4_1744315385.xml

</DOCUMENT>
</SEC-DOCUMENT>